日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

KRAS mutations in colorectal cancer patients receiving trifluridine/tipiracil plus bevacizumab: something to consider

接受三氟尿苷/替吡嘧啶联合贝伐单抗治疗的结直肠癌患者的KRAS突变：值得考虑

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105900
Rizzo, A; Brunetti, O; Brandi, G
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: the real challenge?

胆管癌患者若存在 FGFR2 融合/重排但对 pemigatinib 原发性耐药：真正的挑战是什么？

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103936
Rizzo, A; Ricci, A D; Brandi, G
肿瘤
胆管癌
FGFR2
肿瘤免疫
发表日期：2024
文献求助 收藏

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors

肌肉骨骼肿瘤协会评分系统是一种有效的主观和客观工具，可用于评估上肢和下肢肿瘤患者手术治疗的效果。

期刊:Musculoskeletal Surgery
影响因子:
doi:10.1007/s12306-024-00815-3
Rizzo, A; Paderno, M; Saccomanno, M F; Milano, F; Milano, G
肿瘤免疫
肿瘤
发表日期：2024
文献求助 收藏

Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis

化疗免疫疗法作为三阴性乳腺癌新辅助治疗的停药率和严重不良事件：系统评价和荟萃分析

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.102198
Rizzo, A; Schipilliti, F M; Di Costanzo, F; Acquafredda, S; Arpino, G; Puglisi, F; Del Mastro, L; Montemurro, F; De Laurentiis, M; Giuliano, M
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Role of a corrugated Dion-Jacobson 2D perovskite as an additive in 3D MAPbBr(3) perovskite-based light emitting diodes

波纹状Dion-Jacobson二维钙钛矿作为添加剂在三维MAPbBr(3)钙钛矿基发光二极管中的作用

期刊:Nanoscale Advances
影响因子:4.6
doi:10.1039/d2na00942k
Prontera, C T; Taurino, D; Coriolano, A; Maggiore, A; Pugliese, M; Giannuzzi, R; Mariano, F; Carallo, S; Rizzo, A; Gigli, G; De Marco, L; Maiorano, V
发表日期：2023
文献求助 收藏

Bile cell‑free DNA: a game changer for management of biliary tract cancer?

胆汁游离DNA：胆道癌治疗的变革性突破？

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100389
Rizzo, A; Ricci, A D; Brandi, G
肿瘤
胆管癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection

对一名免疫功能低下且SARS-CoV-2感染持续时间较长的患者进行病毒免疫学评估

期刊:Emerging Microbes & Infections
影响因子:7.5
doi:10.1080/22221751.2022.2045877
Mancon, A; Rizzo, A; Mileto, D; Grosso, S; Foschi, A; Cutrera, M; Capetti, A; Faggion, I; Anselmo, A; Monte, A; Fillo, S; Rizzardini, G; Gismondo, M R; Micheli, V
炎症/感染
免疫/内分泌
SARS-CoV-2
微生物学
发表日期：2022
文献求助 收藏

Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study

瑞戈非尼治疗转移性胃肠道间质瘤的标准方案与个体化方案的比较：一项回顾性、多中心、真实世界研究

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100222
Nannini, M; Rizzo, A; Nigro, M C; Vincenzi, B; Mazzocca, A; Grignani, G; Merlini, A; D'Ambrosio, L; Tolomeo, F; Badalamenti, G; Incorvaia, L; Bonasera, A; Fumagalli, E; Miliziano, D; Ligorio, F; Brunello, A; Chiusole, B; Gasperoni, S; Novelli, M; Pantaleo, M A
发表日期：2021
文献求助 收藏

SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response

SARS-CoV-2 mRNA疫苗BNT162b2可诱导一致的跨变异株体液和细胞免疫应答。

期刊:Emerging Microbes & Infections
影响因子:7.5
doi:10.1080/22221751.2021.2004866
Mileto, D; Fenizia, C; Cutrera, M; Gagliardi, G; Gigantiello, A; De Silvestri, A; Rizzo, A; Mancon, A; Bianchi, M; De Poli, F; Cuomo, M; Burgo, I; Longo, M; Rimoldi, S G; Pagani, C; Grosso, S; Micheli, V; Rizzardini, G; Grande, R; Biasin, M; Gismondo, M R; Lombardi, A
SARS-CoV-2
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms

关于免疫原性细胞死亡在妊娠滋养细胞肿瘤治疗中可能存在的相关性的假设

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2021.101224
Frega, G; Kepp, O; Turchetti, D; Rizzo, A; Pantaleo, M A; Brandi, G
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏